View in EDS HTML Full Text PDF Full Text

Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial.

Saved in:
Bibliographic Details
Title: Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial.
Authors: Barroso-Sousa R; Oncology Center, Hospital Sírio-Libanês Brasília, Brasília, Brazil., Tarantino P; European Institute of Oncology IRCCS, Milan, Italy.; University of Milan, Milan, Italy.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Tayob N; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Dang C; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yardley DA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA., Isakoff SJ; Massachusetts General Hospital, Boston, MA, USA., Valero V; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Faggen M; Dana-Farber Cancer Institute, Boston, MA, USA., Mulvey T; Massachusetts General Hospital, Boston, MA, USA., Bose R; Washington University, St Louis, MO, USA., Hu J; Dana-Farber Cancer Institute, Boston, MA, USA., Weckstein D; Dana-Farber Cancer Institute, Boston, MA, USA., Wolff AC; Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA., Reeder-Hayes K; UNC Chapel Hill, Chapel Hill, NC, USA., Rugo HS; UCSF, San Francisco, CA, USA., Ramaswamy B; OSU Comprehensive Cancer Center, Columbus, OH, USA., Zuckerman D; St Luke's Mountain States Tumor Institute, Boise, ID, USA., Hart L; Wake Forest Baptist Health, Winston-Salem, NC, USA., Gadi VK; University of Washington, Seattle, WA, USA.; Vijayakrishna K. Gadi's current affiliation is University of Illinois at Chicago, Chicago, IL, USA., Constantine M; Dana-Farber Cancer Institute, Boston, MA, USA., Cheng K; North Shore-LIJ Cancer Institute, Lake Success, NY, USA., Briccetti F; Dana-Farber Cancer Institute, Boston, MA, USA., Schneider B; IU School of Medicine, Indianapolis, IN, USA., Garrett AM; Northern Light Cancer Care, Brewer, ME, USA., Marcom K; Duke University, Durham, NC, USA., Albain K; Loyola University Medical Center, Maywood, IL, USA., DeFusco P; Hartford Healthcare Cancer Institute, Hartford, CT, USA., Tung N; Harvard Medical School, Boston, MA, USA.; Beth Israel Deaconess Medical Center, Boston, MA, USA., Ardman B; Lowell General Hospital, Lowell, MA, USA., Nanda R; The University of Chicago, Chicago, IL, USA., Jankowitz RC; Abramsom Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Pohlmann PR; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA., Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL, USA., Liu M; Mayo Clinic, Rochester, MN, USA., Ruddy KJ; Mayo Clinic, Rochester, MN, USA., Zheng Y; Dana-Farber Cancer Institute, Boston, MA, USA., Rosenberg SM; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Weill Cornell Medicine, New York, NY, USA., Gelber RD; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Trippa L; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Barry W; Dana-Farber Cancer Institute, Boston, MA, USA., DeMeo M; Dana-Farber Cancer Institute, Boston, MA, USA., Burstein H; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Partridge A; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Winer EP; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Krop I; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Tolaney SM; Dana-Farber Cancer Institute, Boston, MA, USA. Sara_Tolaney@DFCI.HARVARD.EDU.; Harvard Medical School, Boston, MA, USA. Sara_Tolaney@DFCI.HARVARD.EDU.
Source: NPJ breast cancer [NPJ Breast Cancer] 2022 Feb 16; Vol. 8 (1), pp. 18. Date of Electronic Publication: 2022 Feb 16.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35173164
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Barroso-Sousa+R%22">Barroso-Sousa R</searchLink>; Oncology Center, Hospital Sírio-Libanês Brasília, Brasília, Brazil.<br /><searchLink fieldCode="AU" term="%22Tarantino+P%22">Tarantino P</searchLink>; European Institute of Oncology IRCCS, Milan, Italy.; University of Milan, Milan, Italy.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tayob+N%22">Tayob N</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dang+C%22">Dang C</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Yardley+DA%22">Yardley DA</searchLink>; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Isakoff+SJ%22">Isakoff SJ</searchLink>; Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Valero+V%22">Valero V</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Faggen+M%22">Faggen M</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mulvey+T%22">Mulvey T</searchLink>; Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bose+R%22">Bose R</searchLink>; Washington University, St Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Hu+J%22">Hu J</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Weckstein+D%22">Weckstein D</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wolff+AC%22">Wolff AC</searchLink>; Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Reeder-Hayes+K%22">Reeder-Hayes K</searchLink>; UNC Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; UCSF, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ramaswamy+B%22">Ramaswamy B</searchLink>; OSU Comprehensive Cancer Center, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Zuckerman+D%22">Zuckerman D</searchLink>; St Luke's Mountain States Tumor Institute, Boise, ID, USA.<br /><searchLink fieldCode="AU" term="%22Hart+L%22">Hart L</searchLink>; Wake Forest Baptist Health, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Gadi+VK%22">Gadi VK</searchLink>; University of Washington, Seattle, WA, USA.; Vijayakrishna K. Gadi's current affiliation is University of Illinois at Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Constantine+M%22">Constantine M</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cheng+K%22">Cheng K</searchLink>; North Shore-LIJ Cancer Institute, Lake Success, NY, USA.<br /><searchLink fieldCode="AU" term="%22Briccetti+F%22">Briccetti F</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schneider+B%22">Schneider B</searchLink>; IU School of Medicine, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Garrett+AM%22">Garrett AM</searchLink>; Northern Light Cancer Care, Brewer, ME, USA.<br /><searchLink fieldCode="AU" term="%22Marcom+K%22">Marcom K</searchLink>; Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Albain+K%22">Albain K</searchLink>; Loyola University Medical Center, Maywood, IL, USA.<br /><searchLink fieldCode="AU" term="%22DeFusco+P%22">DeFusco P</searchLink>; Hartford Healthcare Cancer Institute, Hartford, CT, USA.<br /><searchLink fieldCode="AU" term="%22Tung+N%22">Tung N</searchLink>; Harvard Medical School, Boston, MA, USA.; Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ardman+B%22">Ardman B</searchLink>; Lowell General Hospital, Lowell, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nanda+R%22">Nanda R</searchLink>; The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Jankowitz+RC%22">Jankowitz RC</searchLink>; Abramsom Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Rimawi+M%22">Rimawi M</searchLink>; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Abramson+V%22">Abramson V</searchLink>; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Pohlmann+PR%22">Pohlmann PR</searchLink>; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Van+Poznak+C%22">Van Poznak C</searchLink>; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; Kirklin UAB Hematology Oncology, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Liu+M%22">Liu M</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Ruddy+KJ%22">Ruddy KJ</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Zheng+Y%22">Zheng Y</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rosenberg+SM%22">Rosenberg SM</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Gelber+RD%22">Gelber RD</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Trippa+L%22">Trippa L</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Barry+W%22">Barry W</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22DeMeo+M%22">DeMeo M</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Burstein+H%22">Burstein H</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Partridge+A%22">Partridge A</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Winer+EP%22">Winer EP</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Krop+I%22">Krop I</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tolaney+SM%22">Tolaney SM</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA. Sara_Tolaney@DFCI.HARVARD.EDU.; Harvard Medical School, Boston, MA, USA. Sara_Tolaney@DFCI.HARVARD.EDU.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2022 Feb 16; Vol. 8 (1), pp. 18. <i>Date of Electronic Publication: </i>2022 Feb 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35173164
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-022-00385-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 18
    Titles:
      – TitleFull: Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Barroso-Sousa R
      – PersonEntity:
          Name:
            NameFull: Tarantino P
      – PersonEntity:
          Name:
            NameFull: Tayob N
      – PersonEntity:
          Name:
            NameFull: Dang C
      – PersonEntity:
          Name:
            NameFull: Yardley DA
      – PersonEntity:
          Name:
            NameFull: Isakoff SJ
      – PersonEntity:
          Name:
            NameFull: Valero V
      – PersonEntity:
          Name:
            NameFull: Faggen M
      – PersonEntity:
          Name:
            NameFull: Mulvey T
      – PersonEntity:
          Name:
            NameFull: Bose R
      – PersonEntity:
          Name:
            NameFull: Hu J
      – PersonEntity:
          Name:
            NameFull: Weckstein D
      – PersonEntity:
          Name:
            NameFull: Wolff AC
      – PersonEntity:
          Name:
            NameFull: Reeder-Hayes K
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Ramaswamy B
      – PersonEntity:
          Name:
            NameFull: Zuckerman D
      – PersonEntity:
          Name:
            NameFull: Hart L
      – PersonEntity:
          Name:
            NameFull: Gadi VK
      – PersonEntity:
          Name:
            NameFull: Constantine M
      – PersonEntity:
          Name:
            NameFull: Cheng K
      – PersonEntity:
          Name:
            NameFull: Briccetti F
      – PersonEntity:
          Name:
            NameFull: Schneider B
      – PersonEntity:
          Name:
            NameFull: Garrett AM
      – PersonEntity:
          Name:
            NameFull: Marcom K
      – PersonEntity:
          Name:
            NameFull: Albain K
      – PersonEntity:
          Name:
            NameFull: DeFusco P
      – PersonEntity:
          Name:
            NameFull: Tung N
      – PersonEntity:
          Name:
            NameFull: Ardman B
      – PersonEntity:
          Name:
            NameFull: Nanda R
      – PersonEntity:
          Name:
            NameFull: Jankowitz RC
      – PersonEntity:
          Name:
            NameFull: Rimawi M
      – PersonEntity:
          Name:
            NameFull: Abramson V
      – PersonEntity:
          Name:
            NameFull: Pohlmann PR
      – PersonEntity:
          Name:
            NameFull: Van Poznak C
      – PersonEntity:
          Name:
            NameFull: Forero-Torres A
      – PersonEntity:
          Name:
            NameFull: Liu M
      – PersonEntity:
          Name:
            NameFull: Ruddy KJ
      – PersonEntity:
          Name:
            NameFull: Zheng Y
      – PersonEntity:
          Name:
            NameFull: Rosenberg SM
      – PersonEntity:
          Name:
            NameFull: Gelber RD
      – PersonEntity:
          Name:
            NameFull: Trippa L
      – PersonEntity:
          Name:
            NameFull: Barry W
      – PersonEntity:
          Name:
            NameFull: DeMeo M
      – PersonEntity:
          Name:
            NameFull: Burstein H
      – PersonEntity:
          Name:
            NameFull: Partridge A
      – PersonEntity:
          Name:
            NameFull: Winer EP
      – PersonEntity:
          Name:
            NameFull: Krop I
      – PersonEntity:
          Name:
            NameFull: Tolaney SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 02
              Text: 2022 Feb 16
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1